Back to top
more

VanEck Pharmaceutical ETF: (PPH)

(Delayed Data from NASDAQ) As of Nov 16, 2026 04:00 PM ET

$121.59 USD

121.59
197,323

-1.06 (-0.86%)

Volume: 197,323

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

Zacks News

Sweta Killa headshot

Pharma ETFs in Focus Post Q3 Earnings

The Q3 earnings picture for the healthcare sector seems solid, with results from companies that have reported so far up 2.1% on 5.8% revenue growth.

Sweta Killa headshot

JNJ Beats on Q3 Earnings: ETFs in Focus

Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It outpaced revenue estimates and raised its full-year revenue guidance.

Zacks Equity Research

Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

Smart Beta ETF report for PJP

Zacks Equity Research

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Sector ETF report for IHE

Zacks Equity Research

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

Zacks Equity Research

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

Zacks Equity Research

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Sector ETF report for PPH